Kobo Biotech Ltd

NSE: AVONLIFE · BSE: 531541 · Pharmaceuticals & Biotechnology · 6 announcements

Share price: ₹3.69
Market cap: ₹8.79 Cr
Revenue (annual): ₹0.00 Cr
Net profit (annual): ₹-4.93 Cr
P/E (TTM): -1.8×Sector 49.1×
Promoter holding: 44.95%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Insolvency Petition 3 Debt & Borrowing 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

15 Apr 2026 11:51 IST BSE

Debt & Borrowing

Kobo Biotech Debt & Borrowing

Kobo Biotech Limited confirmed it does not meet the criteria for classification as a 'Large Corporate' (LC) as of March 31, 2026. This disclosure follows SEBI's framework regarding debt securities issuance by large entities.

Read the filing ↗